247 related articles for article (PubMed ID: 8116231)
1. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus.
Tieber VL; Zalinskis LL; Silva RF; Finkelstein A; Coussens PM
Virology; 1990 Dec; 179(2):719-27. PubMed ID: 2173259
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
4. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
5. In vivo events of retroviral long terminal repeat integration into Marek's disease virus in commercial poultry: detection of chimeric molecules as a marker.
Davidson I; Borenshtain R
Avian Dis; 2001; 45(1):102-21. PubMed ID: 11332471
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4.
Pratt WD; Cantello J; Morgan RW; Schat KA
Virology; 1994 May; 201(1):132-6. PubMed ID: 8178477
[TBL] [Abstract][Full Text] [Related]
7. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
[TBL] [Abstract][Full Text] [Related]
8. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of the two promoters of SFV-3 by different mechanisms.
Renne R; Fleps U; Luciw PA; Neumann-Haefelin D
Virology; 1996 Jul; 221(2):362-7. PubMed ID: 8661448
[TBL] [Abstract][Full Text] [Related]
11. Expression of the endogenous Marek's disease virus ICP4 homolog (MDV ICP4) gene is enhanced in latently infected cells by transient transfection with the recombinant MDV ICP4 gene.
Endoh D; Ikegawa S; Kon Y; Hayashi M; Sato F
Jpn J Vet Res; 1995 Dec; 43(3-4):109-24. PubMed ID: 8901028
[TBL] [Abstract][Full Text] [Related]
12. Multiple infection of chickens and turkeys with avian oncogenic viruses: prevalence and molecular analysis.
Davidson I; Borenstein R
Acta Virol; 1999; 43(2-3):136-42. PubMed ID: 10696434
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
14. Defective Marek's disease virus DNA contains a gene encoding a potential nuclear DNA binding protein and a HSV a-like sequence.
Camp HS; Silva RF; Coussens PM
Virology; 1993 Oct; 196(2):484-95. PubMed ID: 8396799
[TBL] [Abstract][Full Text] [Related]
15. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV.
Peng Q; Zeng M; Bhuiyan ZA; Ubukata E; Tanaka A; Nonoyama M; Shirazi Y
Virology; 1995 Nov; 213(2):590-9. PubMed ID: 7491783
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel transcripts complementary to the Marek's disease virus homologue of the ICP4 gene of herpes simplex virus.
Li DS; Pastorek J; Zelník V; Smith GD; Ross LJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1713-22. PubMed ID: 8021600
[TBL] [Abstract][Full Text] [Related]
18. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
Omar AR; Schat KA
Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
[TBL] [Abstract][Full Text] [Related]
19. Complete nucleotide sequence of the Marek's disease virus ICP4 gene.
Anderson AS; Francesconi A; Morgan RW
Virology; 1992 Aug; 189(2):657-67. PubMed ID: 1322594
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus insertion into herpesvirus: characterization of a Marek's disease virus harboring a solo LTR.
Kost R; Jones D; Isfort R; Witter R; Kung HJ
Virology; 1993 Jan; 192(1):161-9. PubMed ID: 8390750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
